Raiffeisen Bank International’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Hold
60,000
0.01% 386
2025
Q4
$967K Hold
60,000
0.01% 354
2025
Q3
$754K Hold
60,000
0.01% 379
2025
Q2
$682K Sell
60,000
-44,977
-43% -$533K 0.01% 327
2025
Q1
$1.61M Buy
104,977
+5,014
+5% +$83.9K 0.03% 233
2024
Q4
$1.71M Buy
+99,963
New +$1.93M 0.03% 227

Other funds holding CLB

Raiffeisen Bank International's CLB Position: Q1 2026 in Review

Raiffeisen Bank International held its Core Laboratories (CLB) position steady in Q1 2026 at 60,000 shares worth $1.01M. The position accounts for 0.01% of the portfolio, ranked #386.

Raiffeisen Bank International first reported a position in CLB in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.71M in Q4 2024. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Raiffeisen Bank International held 60,000 shares of Core Laboratories worth $1.01M as of Q1 2026.
  • Raiffeisen Bank International left its Core Laboratories share count unchanged in Q1 2026.
  • Core Laboratories made up 0.01% of Raiffeisen Bank International's portfolio in Q1 2026, its #386 holding.
  • Raiffeisen Bank International first reported a position in Core Laboratories in Q4 2024 and has held it in 6 quarters since.
  • Raiffeisen Bank International's Core Laboratories position peaked at $1.71M in Q4 2024.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.